{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-26-000047","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2026-06-22T13:13:14+00:00","discovered_at":"2026-06-22T13:14:01.407203+00:00","generated_at":"2026-06-22T13:14:09.722348+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspira Women's Health CEO Michael Buhle departs; Chairman John Fraser named interim CEO","bullets":["Michael Buhle ceased as CEO effective June 17, 2026; no disagreement with company operations.","Board appointed Chairman John Fraser as Interim CEO and Principal Executive Officer.","Separation agreement with Buhle not yet finalized; Company will file amendment within 4 business days.","John Fraser, age 66, is co-founder and co-portfolio manager of Seamark Capital."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-26-000047","json":"https://secwatch.observer/filing/0000926617-26-000047.json","markdown":"https://secwatch.observer/filing/0000926617-26-000047.md","text":"https://secwatch.observer/filing/0000926617-26-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/awhl-20260617x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T13:14:09.722348+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17895a8895","claim":"John Fraser was appointed as Interim Chief Executive Officer at Aspira Women's Health Inc..","evidence_excerpt":"Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"19695cbb0e","claim":"Michael Buhle departed as Chief Executive Officer at Aspira Women's Health Inc..","evidence_excerpt":"On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the \"Company\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661726000047/0000926617-26-000047-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}